Part VII : Interventions

Show simple item record

dc.contributor.author Visser, Adele
dc.contributor.author Moore, D.P.
dc.contributor.author Whitelaw, Andrew
dc.contributor.author Lowman, W.
dc.contributor.author Kantor, G.
dc.contributor.author Hoosen, Anwar Ahmed
dc.contributor.author Madhi, Shabir A.
dc.contributor.author Brink, A.
dc.contributor.author Van den Bergh, D.
dc.contributor.author Devenish, L.
dc.contributor.author Moodley, P.
dc.contributor.author Apalata, T.
dc.contributor.author Duse, A.G.
dc.contributor.author Gelband, H.
dc.date.accessioned 2011-10-07T14:19:01Z
dc.date.available 2011-10-07T14:19:01Z
dc.date.issued 2011-08
dc.description.abstract Antimicrobial resistance (AMR) surveillance activities in South Africa have been described in Part V of this report. Surveillance – knowing the levels of resistance and the trends around the country and in different types of institutions – is essential, but is only useful to the extent that the data influence practice. That link is not made automatically, nor is it always easy. Choices must be made among the available interventions based on what will work best in a given situation, and taking into consideration feasibility, cost, likely impact, acceptability to patients and providers, political will, etc. Clearly, surveillance and recent studies can inform revisions of the essential drugs list (EDL) and standard treatment guidelines (STGs). What is more difficult but still possible is that these data can influence and change antibiotic prescribing practices and result in policy formulation geared to limit inappropriate antibiotic use and, consequently, AMR and its spread. However, so far the efficacy and clinical outcomes of both EDLs and STGs have, since their implementation, not been adequately evaluated. Reducing the burden of infectious diseases also reduces the need for antibiotics but, primarily, prevents illness. Vaccination and infection prevention and control in hospitals and other health care facilities are the two critical interventions in this category. In this section, the status and challenges of all these interventions in South Africa are reviewed. en_US
dc.description.uri http://www.samj.org.za en_US
dc.identifier.citation Visser, A, Moore, DP, Whitelaw, A, Lowman, W, Kantor, G, Hoosen, A, Madhi, S, Brink, A, Van den Bergh, D, Devenish, L, Apalata, T, Duse, AG & Gelband, H 2011, 'Part VII : Interventions', South African Medical Journal, vol. 101, no. 8, pp. 587-595 en_US
dc.identifier.issn 2078-5135 (online)
dc.identifier.issn 0256-9574 (print)
dc.identifier.uri http://hdl.handle.net/2263/17412
dc.language.iso en en_US
dc.publisher Health and Medical Publishing Group en_US
dc.rights Health and Medical Publishing Group en_US
dc.subject Antibiotic resistance en_US
dc.subject Surveillance en_US
dc.subject Infection control en_US
dc.subject Vaccination en_US
dc.subject Prescribing practices en_US
dc.subject Standard Treatment Guidelines en_US
dc.subject.lcsh Diagnosis en
dc.title Part VII : Interventions en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record